Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
The AAPS Journal|January 17, 2014
Headway and hurdles in the clinical development of dietary phytochemicals for cancer therapy and prevention: lessons learned from vitamin A derivativesChristina Y Yim, Pingping Mao, Michael J SpinellaHeliyon|June 17, 2024
Evaluation of stored red blood cell quality after washing using immune indicesGuangchao Zhao, Hongmei Zhang, Xiaojun Kong, et al.Cancer Research|July 14, 2021
Cell Line-Specific Network Models of ER+ Breast Cancer Identify Potential PI3Kα Inhibitor Resistance Mechanisms and Drug CombinationsJorge Gómez Tejeda Zañudo, Pingping Mao, Clara Alcon, et al.Plos One|December 7, 2013
Serine/threonine kinase 17A is a novel candidate for therapeutic targeting in glioblastomaPingping Mao, Mary P Hever-Jardine, Gilbert J Rahme, et al.The Journal of Biological Chemistry|April 15, 2011
Serine/threonine kinase 17A is a novel p53 target gene and modulator of cisplatin toxicity and reactive oxygen species in testicular cancer cellsPingping Mao, Mary P Hever, Lynne M Niemaszyk, et al.Cancer Immunology Research|January 21, 2026
Anti-B-cell maturation antigen chimeric antigen receptor T-cell therapy bb21217 for relapsed and refractory multiple myeloma: results from the phase 1 CRB-402 studyMelissa Alsina, Nina Shah, Sundar Jagannath, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 30, 2020
Acquired FGFR and FGF Alterations Confer Resistance to Estrogen Receptor (ER) Targeted Therapy in ER+ Metastatic Breast CancerPingping Mao, Ofir Cohen, Kailey J Kowalski, et al.Cancer Discovery|May 15, 2020
The Genomic Landscape of Intrinsic and Acquired Resistance to Cyclin-Dependent Kinase 4/6 Inhibitors in Patients with Hormone Receptor-Positive Metastatic Breast CancerSeth A Wander, Ofir Cohen, Xueqian Gong, et al.Pageof 1